UK Diagnostic Capacity And Spending Below European Average
The UK’s diagnostics sector has faced “significant underinvestment” over recent years, according to researchers at health think tank The King’s Fund. A new report shows how the UK’s spending on diagnostics compares to other European countries.
You may also be interested in...
Genomic diagnostics provide significant value to the health system, but England’s unclear funding pathways and commissioning processes are preventing these tests from reaching patients, a report by trade body BIVDA reveals.
A report comparing the health technology assessment methods used in nine European countries, Australia and Canada found that England has the most favorable reimbursement landscape for gene therapies – but outlined several areas for improvement across the board.
The European Commission’s proposals to overhaul the EU pharma legislation, which will see some orphan drug incentives cut, would cause a “significant dip in innovation,” according to number crunching from pharma industry association EFPIA.